정장한 교수
전문진료분야
간질환; 급성 및 만성 바이러스간염, 알코올성 간질환, 대사이상지방간질환, 간경변증, 간세포암
전화 예약
1522-2500
기본정보
학력
2006건양대학교 의과대학 졸업 2011건양대학교 일반대학원 의학 석사 |
경력
2006 ~ 2011건양대학교병원 수련/전공의 수료 2015 ~ 2017연세대학교세브란스병원 소화기내과 임상강사/임상연구조교수 2017 ~ 2019한림대학교동탄성심병원 소화기내과 임상조교수 2019 ~ 한림대학교동탄성심병원 소화기내과 조교수 |
학회활동
대한내과학회 대한소화기학회 대한소화기내시경학회 대한간학회 대한간암학회 대한임상초음파학회 |
논문
국내학회지 발표논문
1. Long-Term Mortality Following Hepatitis C Cure in a Real-World Multinational Cohort. Ji F, Tran S, Toyoda H, Enomoto M, Ogawa E, Suzuki T, Huang CF, Wong YJ, Chuma M, Uojima H, Atsukawa M, Hsu YC, Jun DW, Nozaki A, Tseng CH, Ishigami M, Honda T, Trinh H, Watanabe T, Abe H, Preda C, Lee DH, Ishikawa T, Haga H, Liang J, Takahashi H, Vutien P, Landis C, Li J, Takaguchi K, Senoh T, Huang R, Wong GL, Wong VW, Lam CP, Huang DQ, Asai A, Ye Q, Do AT, Do S, Itokawa N, Nakamuta M, Nomura H, Kajiwara E, Azuma K, Dohmen K, Kawano A, Koyanagi T, Ooho A, Satoh T, Takahashi K, Yoon EL, Ahn SB, Jung JH, Kim SE, Kim GA, Jeong SW, Oh H, Yasuda S, Gao X, Zhao Y, Liu Y, Zhao C, Okubo T, Jun MJ, Alecu RI, Tay WX, Devan P, Liu JK, Kozuka R, Vargas-Accarino E, Inoue K, Maeda M, Eguchi Y, Ueno Y, Chuang WL, Huang JF, Dai CY, Henry L, Cheung R, Yeh ML, Tsai PC, Buti M, Lim SG, Wu C, Yuen MF, Furusyo N, Hayashi J, Yu ML, Tanaka Y, Nguyen MH. Liver Int. 2026 Mar;46(3):e70561. doi: 10.1111/liv.70561. PMID: 41724904.
2. Clinical impact of percutaneous transhepatic gallbladder drainage followed by laparoscopic cholecystectomy in patients with moderate to severe acute cholecystitis: A propensity score-matched case-control study. Lee KJ, Jung JH, Park SW, Park DH, Cha HW, Koh DH, Lee J, Lee JM, Lee JW, Cho E. Am J Surg. 2026 Feb;252:116737. doi: 10.1016/j.amjsurg.2025.116737. Epub 2025 Nov 19. PMID: 41317682.
3. Impact of the 2024 medical-policy conflict on hepatocellular carcinoma management in Korea. Kim SS, Yang H, Kwon J, Kim E, Yu JI, Jung J, Choi W, Han JE, Hur MH, Kim BH, Kim SH, Kim JH, Kim H, Park PJ, Shin HP, Yu SJ, Yoon KT, Yoon SM, Lee M, Cho JY, Choi JY, Kim DY, Lee JS, Kim MS, Kim KS. J Liver Cancer. 2025 Sep;25(2):169-177. doi: 10.17998/jlc.2025.09.01. Epub 2025 Sep 2. PMID: 40899157; PMCID: PMC12518984.
4. Expert survey on systemic therapy indications for hepatocellular carcinoma in Korea: bridging clinical practice and reimbursement criteria. Yang H, Kim SS, Kang SH, Kwon J, Kim DY, Kim E, Shin HP, Yu JI, Yoo JJ, Yoon EL, Lee S, Chon YE, Jung J, Cheon J, Choi W, Han SK, Han JE, Hur MH, Lee HW, Kim HJ. J Liver Cancer. 2025 Sep;25(2):160-168. doi: 10.17998/jlc.2025.07.02. Epub 2025 Jul 7. PMID: 40623830; PMCID: PMC12518990.
5. Early risk stratification of post-endoscopic retrograde cholangiopancreatography pancreatitis using 4-hour serum amylase and lipase: A prospective study. Jung JH, Lee KJ, Park SW, Park DH, Cha HW, Koh DH, Lee J. World J Gastroenterol. 2025 Oct 21;31(39):111265. doi: 10.3748/wjg.v31.i39.111265. PMID: 41180791; PMCID: PMC12576598.
6. Point-of-Care Testing and Biomarkers in Biliary Diseases: Current Evidence and Future Directions. Jung JH, Lee KJ, Park SW, Koh DH, Lee J. J Clin Med. 2025 Sep 24;14(19):6724. doi: 10.3390/jcm14196724. PMID: 41095804; PMCID: PMC12524950.
7. Impact of Concurrent Steatotic Liver Disease and Chronic Hepatitis B on Treatment Response to Nucleos(t)ide Analogs. Chau A, Li J, Jun DW, Hsu YC, Toyoda H, Yeh ML, Watanabe T, Honda T, Trinh H, Nozaki A, Uojima H, Ishikawa T, Huang DQ, Vutien P, Marciano S, Abe H, Atsukawa M, Enomoto M, Takahashi H, Tsuji K, Takaguchi K, Itobayashi E, Huang R, Tsai PC, Dai CY, Huang JF, Huang CF, Yoon E, Kim SE, Ahn SB, Kim GA, Jung JH, Jeong SW, Oh H, Hsiao T, Maeda M, Tseng CH, Yasuda S, Ishigami M, Chuma M, Ito T, Kawashima K, Liu JK, Itokawa N, Kozuka R, Inoue K, Senoh T, Chuang WL, Gadano A, Tanaka Y, Lim SG, Wu C, Cheung R, Yu ML, Nguyen MH. J Viral Hepat. 2025 Oct;32(10):e70081. doi: 10.1111/jvh.70081. PMID: 40944466.
8. Impact of metabolic dysfunction on treatment responses to nucleos(t)ide analogues in chronic hepatitis B: a retrospective multi-center REAL-B cohort study. Huang R, Jun DW, Toyoda H, Hsu YC, Trinh H, Nozaki A, Ishikawa T, Watanabe T, Uojima H, Huang DQ, Honda T, Tanaka Y, Vutien P, Marciano S, Abe H, Enomoto M, Atsukawa M, Takahashi H, Tsuji K, Itobayashi E, Takaguchi K, Tsai PC, Dai CY, Huang JF, Huang CF, Yeh ML, Yoon E, Kim SE, Ahn SB, Kim GA, Jung JH, Jeong SW, Oh H, Tseng CH, Ishigami M, Chau A, Hsiao T, Maeda M, Yasuda S, Chuma M, Ito T, Kawashima K, Liu JK, Gadano A, Kozuka R, Itokawa N, Inoue K, Senoh T, Li J, Chuang WL, Cheung R, Wu C, Yu ML, Nguyen MH. EClinicalMedicine. 2025 Aug 11;87:103407. doi: 10.1016/j.eclinm.2025.103407. PMID: 40831465; PMCID: PMC12359161.
9. Impacts of metabolic syndrome diseases on long-term outcomes of chronic hepatitis B patients treated with nucleos(t)ide analogues. Huang R, Jun DW, Toyoda H, Hsu YC, Trinh H, Nozaki A, Ishikawa T, Watanabe T, Uojima H, Huang DQ, Honda T, Tanaka Y, Vutien P, Marciano S, Abe H, Enomoto M, Atsukawa M, Takahashi H, Tsuji K, Takaguchi K, Tsai PC, Dai CY, Huang JF, Huang CF, Yeh ML, Yoon E, Kim SE, Ahn SB, Kim GA, Jung JH, Jeong SW, Oh H, Tseng CH, Ishigami M, Chau A, Maeda M, Yasuda S, Chuma M, Ito T, Kawashima K, Liu JK, Gadano A, Kozuka R, Itokawa N, Inoue K, Senoh T, Li J, Chuang WL, Cheung R, Wu C, Yu ML, Nguyen MH. Clin Mol Hepatol. 2025 Jul;31(3):1003-1017. doi: 10.3350/cmh.2024.1070. Epub 2025 Mar 17. PMID: 40091278; PMCID: PMC12260618.
10. Mortality in patients with chronic hepatitis B treated with tenofovir or entecavir: A multinational study. Jang TY, Liang PC, Jun DW, Jung JH, Toyoda H, Wang CW, Yuen MF, Cheung KS, Yasuda S, Kim SE, Yoon EL, An J, Enomoto M, Kozuka R, Chuma M, Nozaki A, Ishikawa T, Watanabe T, Atsukawa M, Arai T, Hayama K, Ishigami M, Cho YK, Ogawa E, Kim HS, Shim JJ, Uojima H, Jeong SW, Ahn SB, Takaguchi K, Senoh T, Buti M, Vargas-Accarino I E, Abe H, Takahashi H, Inoue K, Yeh ML, Dai CY, Huang JF, Huang CF, Chuang WL, Nguyen MH, Yu ML. J Gastroenterol Hepatol. 2024 Jun;39(6):1190-1197. doi: 10.1111/jgh.16537. Epub 2024 Mar 13. PMID: 38480009.
11. Pretreatment gamma-glutamyl transferase predicts mortality in patients with chronic hepatitis B treated with nucleotide/nucleoside analogs. Jang TY, Liang PC, Jun DW, Jung JH, Toyoda H, Wang CW, Yuen MF, Cheung KS, Yasuda S, Kim SE, Yoon EL, An J, Enomoto M, Kozuka R, Chuma M, Nozaki A, Ishikawa T, Watanabe T, Atsukawa M, Arai T, Hayama K, Ishigami M, Cho YK, Ogawa E, Kim HS, Shim JJ, Uojima H, Jeong SW, Ahn SB, Takaguchi K, Senoh T, Buti M, Vargas-Accarino E, Abe H, Takahashi H, Inoue K, Huang JF, Chuang WL, Yeh ML, Dai CY, Huang CF, Nguyen MH, Yu ML. Kaohsiung J Med Sci. 2024 Feb;40(2):188-197. doi: 10.1002/kjm2.12771. Epub 2023 Oct 27. PMID: 37885338; PMCID: PMC11895642.
12. A survey on the awareness, current management, and barriers for non-alcoholic fatty liver disease among the general Korean population. Lee JH, Jung JH, Park H, Oh JH, Ahn SB, Yoon EL, Jun DW. Sci Rep. 2023 Sep 14;13(1):15205. doi: 10.1038/s41598-023-42176-0. PMID: 37709931; PMCID: PMC10502016.
13. The diagnostic significance of hepatitis C virus antibody levels for chronic hepatitis C virus infection. Kang JG, Jang MK, Kim JH, Jung JH, Park JW, Kim SE, Park SH, Lee MS, Suk KT, Kim DJ, Kim HS. Korean J Intern Med. 2023 May;38(3):362-371. doi: 10.3904/kjim.2022.350. Epub 2023 Apr 11. PMID: 37038262; PMCID: PMC10175861.
14. Successful Intubation Using a Cap-Assisted Colonoscope for Endoscopic Retrograde Cholangiopancreatography in Patients Undergoing Roux-en-Y Reconstruction. Lee KJ, Park SW, Jang HJ, Park DH, Kim JH, Jung JH, Koh DH, Lee J. J Clin Med. 2023 Feb 8;12(4):1353. doi: 10.3390/jcm12041353. PMID: 36835890; PMCID: PMC9966074.
15. Placement of Plastic Stents after Direct Endoscopic Necrosectomy through a Novel Lumen-Apposing Metal Stent for Effective Treatment of Laterally Extended Walled-Off Necrosis: A Pilot Study. Lee KJ, Park SW, Park DH, Kim JH, Jung JH, Koh DH, Lee J, Kim MG. J Clin Med. 2023 Jan 31;12(3):1125. doi: 10.3390/jcm12031125. PMID: 36769773; PMCID: PMC9917419.
16. Liver-Related Mortality in Hepatitis B Virus Core Antibody+/Hepatitis B Virus Surface Antigen- Patients: Occult Hepatitis B Virus, Hepatitis B Virus Reactivation, and Hepatocellular Carcinoma Development. Jung J, Nguyen MH. Am J Gastroenterol. 2023 Jan 1;118(1):24-25. doi: 10.14309/ajg.0000000000002030. Epub 2022 Sep 16. PMID: 36602834.
17. Serum S100B Levels in Patients with Liver Cirrhosis and Hepatic Encephalopathy. Kim MJ, Kim JH, Jung JH, Kim SE, Kim HS, Jang MK, Park SH, Lee MS, Suk KT, Kim DJ, Choi EK, Park JW. Diagnostics (Basel). 2023 Jan 17;13(3):333. doi: 10.3390/diagnostics13030333.
18. Platelet-to-White Blood Cell Ratio: A Feasible Biomarker for Pyogenic Liver Abscess. Ko DG, Park JW, Kim JH, Jung JH, Kim HS, Suk KT, Jang MK, Park SH, Lee MS, Kim DJ, Kim SE. Diagnostics (Basel). 2022 Oct 21;12(10):2556. doi: 10.3390/diagnostics12102556.
19. Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: Current Knowledge of Pathogenesis and Therapeutics. Park JW, Kim JH, Kim SE, Jung JH, Jang MK, Park SH, Lee MS, Kim HS, Suk KT, Kim DJ. Biomedicines. 2022 May 31;10(6):1288. doi: 10.3390/biomedicines10061288.
20. Gut microbiota-modulating agents in alcoholic liver disease: Links between host metabolism and gut microbiota. Jung JH, Kim SE, Suk KT, Kim DJ. ront Med (Lausanne). 2022 Jul 22;9:913842. doi: 10.3389/fmed.2022.913842. eCollection 2022.
21. A Multicenter Retrospective Study on Clinical Characteristics and Outcome of Pyogenic Liver Abscess Focusing Multidrug-Resistant Organisms. Park JW, Kim JH, Jung JH, Kim SE, Kim HS, Jeong H, Suk KT, Jang MK, Kim DJ, Lee MS, Park SH. J Clin Med. 2022 Feb 19;11(4):1114. doi: 10.3390/jcm11041114.
22. Ursodeoxycholic acid inhibits epithelial-mesenchymal transition, suppressing invasiveness of bile duct cancer cells: An in vitro study. Lee J, Hong EM, Kim JH, Kim JH, Jung JH, Park SW, Koh DH. Oncol Lett. 2022 Oct 26;24(6):448. doi: 10.3892/ol.2022.13568. eCollection 2022 Dec.
23. Minimal and Maximal Extent of Band Ligation for Acute Variceal Bleeding during the First Endoscopic Session. Jung JH, Jo JH, Kim SE, Bang CS, Seo SI, Park CH, Park SW. Gut Liver. 2022 Jan 15;16(1):101-110. doi: 10.5009/gnl20375.
24. Role of Microbiota-Derived Metabolites in Alcoholic and Non-Alcoholic Fatty Liver Diseases. Park JW, Kim SE, Lee NY, Kim JH, Jung JH, Jang MK, Park SH, Lee MS, Kim DJ, Kim HS, Suk KT. Int J Mol Sci. 2021 Dec 31;23(1):426. doi: 10.3390/ijms23010426.
25. Bedside Risk-Scoring Model for Predicting 6-Week Mortality in Cirrhotic Patients Undergoing Endoscopic Band Ligation for Acute Variceal Bleeding. Kim JH, Park SW, Jung JH, Park DH, Bang CS, Park CH, Park JW, Park JG. J Gastroenterol Hepatol. 2021 Feb 4. doi: 10.1111/jgh.15426.
26. Comparison of the Diagnostic Performance of Novel Slim Biopsy Forceps with Conventional Biopsy Forceps for Biliary Stricture: A Multicenter Retrospective Study. Jung ES, Park SW, Kim JH, Jung JH, Yang MJ, Park DH. J Pers Med. 2021 Jan 17;11(1):55. doi: 10.3390/jpm11010055.
27. HCC risk post-SVR with DAAs in East Asians: findings from the REAL-C cohort. Tanaka Y, Ogawa E, Huang CF, Toyoda H, Jun DW, Tseng CH, Hsu YC, Enomoto M, Takahashi H, Furusyo N, Yeh ML, Iio E, Yasuda S, Lam CP, Lee DH, Haga H, Yoon EL, Ahn SB, Wong G, Nakamuta M, Nomura H, Tsai PC, Jung JH, Song DS, Dang H, Maeda M, Henry L, Cheung R, Yuen MF, Ueno Y, Eguchi Y, Tamori A, Yu ML, Hayashi J, Nguyen MH; REAL-C Investigators. Hepatol Int. 2020 Dec;14(6):1023-1033. doi: 10.1007/s12072-020-10105-2.
28. The role of linked color imaging in endoscopic diagnosis of Helicobacter pylori associated gastritis. Lee SP, Lee J, Kae SH, Jang HJ, Koh DH, Jung JH, Byeon SJ. Scand J Gastroenterol. 2020 Sep;55(9):1114-1120. doi: 10.1080/00365521.2020.1794025.
29. Clinical outcomes of sedation during emergency endoscopic band ligation for variceal bleeding: Multicenter cohort study. Park CH, Park SW, Jung JH, Kim GG, Choi SY, Kim ES, In DH, Kim HD. Dig Endosc. 2020 Sep;32(6):894-903. doi: 10.1111/den.13610.
30. Neurologic Safety of Etomidate-Based Sedation during Upper Endoscopy in Patients with Liver Cirrhosis Compared with Propofol: A Double-Blind, Randomized Controlled Trial. Jung JH, Hyun B, Lee J, Koh DH, Kim JH, Park SW. J Clin Med. 2020 Jul 29;9(8):2424. doi: 10.3390/jcm9082424.
31. Comparative efficacy of stents in endoscopic ultrasonography-guided peripancreatic fluid collection drainage: A systematic review and network meta-analysis. Park CH, Park SW, Nam E, Jung JH, Jo JH. J Gastroenterol Hepatol. 2020 Jun;35(6):941-952. doi: 10.1111/jgh.14960.
32. Identification of risk factors for obstructive cholecystitis following placement of biliary stent in unresectable malignant biliary obstruction: a 5-year retrospective analysis in single center. Jung JH, Park SW, Hyun B, Lee J, Koh DH, Chung D. Surg Endosc. 2020 Jun 15. doi: 10.1007/s00464-020-07694-2.
33. Metformin Induces Apoptosis and Inhibits Proliferation through the AMP-Activated Protein Kinase and Insulin-like Growth Factor 1 Receptor Pathways in the Bile Duct Cancer Cells. Lee J, Hong EM, Kim JH, Jung JH, Park SW, Koh DH, Choi MH, Jang HJ, Kae SH. J Cancer. 2019 Apr 5;10(7):1734-1744. doi: 10.7150/jca.26380.
34. Efficacy of submucosal bupivacaine injection for pain relief after endoscopic submucosal dissection: A multicenter, prospective, randomized controlled, and double-blind trial. Jung JH, Jang HJ, Bang CS, Baik GH, Park SW. Medicine (Baltimore). 2019 Apr;98(17):e15360. doi: 10.1097/MD.0000000000015360.
35. Safety and efficacy of early feeding based on clinical assessment at 4 hours after ERCP: a prospective randomized controlled trial. Park CH, Jung JH, Hyun B, Kan HJ, Lee J, Kae SH, Jang HJ, Koh DH, Choi MH, Chung MJ, Bang S, Park SW. Gastrointest Endosc. 2018 Apr;87(4):1040-1049.e1. doi: 10.1016/j.gie.2017.09.021.
36. Endoscopic mucosal resection for intraductal growing-type intrahepatic cholangiocarcinoma under direct peroral cholangioscopy. Jung JH, Park SW, Shin E. Dig Endosc. 2018 Nov;30(6):785-788. doi: 10.1111/den.13256.
37. Comparative efficacy of various endoscopic techniques for the treatment of common bile duct stones: a network meta-analysis. Park CH, Jung JH, Nam E, Kim EH, Kim MG, Kim JH, Park SW. Gastrointest Endosc. 2018 Jan;87(1):43-57.e10. doi: 10.1016/j.gie.2017.07.038.
38. Clinical characteristics of second primary pancreatic cancer. Jo JH, Cho IR, Jung JH, Lee HS, Chung MJ, Bang S, Park SW, Chung JB, Song SY, Park JY. PLoS One. 2017 Jun 26;12(6):e0179784. doi: 10.1371/journal.pone.0179784.
39. Benefit of neoadjuvant concurrent chemoradiotherapy for locally advanced perihilar cholangiocarcinoma. Jung JH, Lee HJ, Lee HS, Jo JH, Cho IR, Chung MJ, Park JY, Park SW, Song SY, Bang S. World J Gastroenterol. 2017 May 14;23(18):3301-3308. doi: 10.3748/wjg.v23.i18.3301.
40. Combination Therapy with Capecitabine and Cisplatin as Second-Line Chemotherapy for Advanced Biliary Tract Cancer. Jung JH, Lee HS, Jo JH, Cho IR, Chung MJ, Bang S, Park SW, Song SY, Park JY. Chemotherapy. 2017;62(6):361-366. doi: 10.1159/000479425.
1. Long-Term Mortality Following Hepatitis C Cure in a Real-World Multinational Cohort. Ji F, Tran S, Toyoda H, Enomoto M, Ogawa E, Suzuki T, Huang CF, Wong YJ, Chuma M, Uojima H, Atsukawa M, Hsu YC, Jun DW, Nozaki A, Tseng CH, Ishigami M, Honda T, Trinh H, Watanabe T, Abe H, Preda C, Lee DH, Ishikawa T, Haga H, Liang J, Takahashi H, Vutien P, Landis C, Li J, Takaguchi K, Senoh T, Huang R, Wong GL, Wong VW, Lam CP, Huang DQ, Asai A, Ye Q, Do AT, Do S, Itokawa N, Nakamuta M, Nomura H, Kajiwara E, Azuma K, Dohmen K, Kawano A, Koyanagi T, Ooho A, Satoh T, Takahashi K, Yoon EL, Ahn SB, Jung JH, Kim SE, Kim GA, Jeong SW, Oh H, Yasuda S, Gao X, Zhao Y, Liu Y, Zhao C, Okubo T, Jun MJ, Alecu RI, Tay WX, Devan P, Liu JK, Kozuka R, Vargas-Accarino E, Inoue K, Maeda M, Eguchi Y, Ueno Y, Chuang WL, Huang JF, Dai CY, Henry L, Cheung R, Yeh ML, Tsai PC, Buti M, Lim SG, Wu C, Yuen MF, Furusyo N, Hayashi J, Yu ML, Tanaka Y, Nguyen MH. Liver Int. 2026 Mar;46(3):e70561. doi: 10.1111/liv.70561. PMID: 41724904.
2. Clinical impact of percutaneous transhepatic gallbladder drainage followed by laparoscopic cholecystectomy in patients with moderate to severe acute cholecystitis: A propensity score-matched case-control study. Lee KJ, Jung JH, Park SW, Park DH, Cha HW, Koh DH, Lee J, Lee JM, Lee JW, Cho E. Am J Surg. 2026 Feb;252:116737. doi: 10.1016/j.amjsurg.2025.116737. Epub 2025 Nov 19. PMID: 41317682.
3. Impact of the 2024 medical-policy conflict on hepatocellular carcinoma management in Korea. Kim SS, Yang H, Kwon J, Kim E, Yu JI, Jung J, Choi W, Han JE, Hur MH, Kim BH, Kim SH, Kim JH, Kim H, Park PJ, Shin HP, Yu SJ, Yoon KT, Yoon SM, Lee M, Cho JY, Choi JY, Kim DY, Lee JS, Kim MS, Kim KS. J Liver Cancer. 2025 Sep;25(2):169-177. doi: 10.17998/jlc.2025.09.01. Epub 2025 Sep 2. PMID: 40899157; PMCID: PMC12518984.
4. Expert survey on systemic therapy indications for hepatocellular carcinoma in Korea: bridging clinical practice and reimbursement criteria. Yang H, Kim SS, Kang SH, Kwon J, Kim DY, Kim E, Shin HP, Yu JI, Yoo JJ, Yoon EL, Lee S, Chon YE, Jung J, Cheon J, Choi W, Han SK, Han JE, Hur MH, Lee HW, Kim HJ. J Liver Cancer. 2025 Sep;25(2):160-168. doi: 10.17998/jlc.2025.07.02. Epub 2025 Jul 7. PMID: 40623830; PMCID: PMC12518990.
5. Early risk stratification of post-endoscopic retrograde cholangiopancreatography pancreatitis using 4-hour serum amylase and lipase: A prospective study. Jung JH, Lee KJ, Park SW, Park DH, Cha HW, Koh DH, Lee J. World J Gastroenterol. 2025 Oct 21;31(39):111265. doi: 10.3748/wjg.v31.i39.111265. PMID: 41180791; PMCID: PMC12576598.
6. Point-of-Care Testing and Biomarkers in Biliary Diseases: Current Evidence and Future Directions. Jung JH, Lee KJ, Park SW, Koh DH, Lee J. J Clin Med. 2025 Sep 24;14(19):6724. doi: 10.3390/jcm14196724. PMID: 41095804; PMCID: PMC12524950.
7. Impact of Concurrent Steatotic Liver Disease and Chronic Hepatitis B on Treatment Response to Nucleos(t)ide Analogs. Chau A, Li J, Jun DW, Hsu YC, Toyoda H, Yeh ML, Watanabe T, Honda T, Trinh H, Nozaki A, Uojima H, Ishikawa T, Huang DQ, Vutien P, Marciano S, Abe H, Atsukawa M, Enomoto M, Takahashi H, Tsuji K, Takaguchi K, Itobayashi E, Huang R, Tsai PC, Dai CY, Huang JF, Huang CF, Yoon E, Kim SE, Ahn SB, Kim GA, Jung JH, Jeong SW, Oh H, Hsiao T, Maeda M, Tseng CH, Yasuda S, Ishigami M, Chuma M, Ito T, Kawashima K, Liu JK, Itokawa N, Kozuka R, Inoue K, Senoh T, Chuang WL, Gadano A, Tanaka Y, Lim SG, Wu C, Cheung R, Yu ML, Nguyen MH. J Viral Hepat. 2025 Oct;32(10):e70081. doi: 10.1111/jvh.70081. PMID: 40944466.
8. Impact of metabolic dysfunction on treatment responses to nucleos(t)ide analogues in chronic hepatitis B: a retrospective multi-center REAL-B cohort study. Huang R, Jun DW, Toyoda H, Hsu YC, Trinh H, Nozaki A, Ishikawa T, Watanabe T, Uojima H, Huang DQ, Honda T, Tanaka Y, Vutien P, Marciano S, Abe H, Enomoto M, Atsukawa M, Takahashi H, Tsuji K, Itobayashi E, Takaguchi K, Tsai PC, Dai CY, Huang JF, Huang CF, Yeh ML, Yoon E, Kim SE, Ahn SB, Kim GA, Jung JH, Jeong SW, Oh H, Tseng CH, Ishigami M, Chau A, Hsiao T, Maeda M, Yasuda S, Chuma M, Ito T, Kawashima K, Liu JK, Gadano A, Kozuka R, Itokawa N, Inoue K, Senoh T, Li J, Chuang WL, Cheung R, Wu C, Yu ML, Nguyen MH. EClinicalMedicine. 2025 Aug 11;87:103407. doi: 10.1016/j.eclinm.2025.103407. PMID: 40831465; PMCID: PMC12359161.
9. Impacts of metabolic syndrome diseases on long-term outcomes of chronic hepatitis B patients treated with nucleos(t)ide analogues. Huang R, Jun DW, Toyoda H, Hsu YC, Trinh H, Nozaki A, Ishikawa T, Watanabe T, Uojima H, Huang DQ, Honda T, Tanaka Y, Vutien P, Marciano S, Abe H, Enomoto M, Atsukawa M, Takahashi H, Tsuji K, Takaguchi K, Tsai PC, Dai CY, Huang JF, Huang CF, Yeh ML, Yoon E, Kim SE, Ahn SB, Kim GA, Jung JH, Jeong SW, Oh H, Tseng CH, Ishigami M, Chau A, Maeda M, Yasuda S, Chuma M, Ito T, Kawashima K, Liu JK, Gadano A, Kozuka R, Itokawa N, Inoue K, Senoh T, Li J, Chuang WL, Cheung R, Wu C, Yu ML, Nguyen MH. Clin Mol Hepatol. 2025 Jul;31(3):1003-1017. doi: 10.3350/cmh.2024.1070. Epub 2025 Mar 17. PMID: 40091278; PMCID: PMC12260618.
10. Mortality in patients with chronic hepatitis B treated with tenofovir or entecavir: A multinational study. Jang TY, Liang PC, Jun DW, Jung JH, Toyoda H, Wang CW, Yuen MF, Cheung KS, Yasuda S, Kim SE, Yoon EL, An J, Enomoto M, Kozuka R, Chuma M, Nozaki A, Ishikawa T, Watanabe T, Atsukawa M, Arai T, Hayama K, Ishigami M, Cho YK, Ogawa E, Kim HS, Shim JJ, Uojima H, Jeong SW, Ahn SB, Takaguchi K, Senoh T, Buti M, Vargas-Accarino I E, Abe H, Takahashi H, Inoue K, Yeh ML, Dai CY, Huang JF, Huang CF, Chuang WL, Nguyen MH, Yu ML. J Gastroenterol Hepatol. 2024 Jun;39(6):1190-1197. doi: 10.1111/jgh.16537. Epub 2024 Mar 13. PMID: 38480009.
11. Pretreatment gamma-glutamyl transferase predicts mortality in patients with chronic hepatitis B treated with nucleotide/nucleoside analogs. Jang TY, Liang PC, Jun DW, Jung JH, Toyoda H, Wang CW, Yuen MF, Cheung KS, Yasuda S, Kim SE, Yoon EL, An J, Enomoto M, Kozuka R, Chuma M, Nozaki A, Ishikawa T, Watanabe T, Atsukawa M, Arai T, Hayama K, Ishigami M, Cho YK, Ogawa E, Kim HS, Shim JJ, Uojima H, Jeong SW, Ahn SB, Takaguchi K, Senoh T, Buti M, Vargas-Accarino E, Abe H, Takahashi H, Inoue K, Huang JF, Chuang WL, Yeh ML, Dai CY, Huang CF, Nguyen MH, Yu ML. Kaohsiung J Med Sci. 2024 Feb;40(2):188-197. doi: 10.1002/kjm2.12771. Epub 2023 Oct 27. PMID: 37885338; PMCID: PMC11895642.
12. A survey on the awareness, current management, and barriers for non-alcoholic fatty liver disease among the general Korean population. Lee JH, Jung JH, Park H, Oh JH, Ahn SB, Yoon EL, Jun DW. Sci Rep. 2023 Sep 14;13(1):15205. doi: 10.1038/s41598-023-42176-0. PMID: 37709931; PMCID: PMC10502016.
13. The diagnostic significance of hepatitis C virus antibody levels for chronic hepatitis C virus infection. Kang JG, Jang MK, Kim JH, Jung JH, Park JW, Kim SE, Park SH, Lee MS, Suk KT, Kim DJ, Kim HS. Korean J Intern Med. 2023 May;38(3):362-371. doi: 10.3904/kjim.2022.350. Epub 2023 Apr 11. PMID: 37038262; PMCID: PMC10175861.
14. Successful Intubation Using a Cap-Assisted Colonoscope for Endoscopic Retrograde Cholangiopancreatography in Patients Undergoing Roux-en-Y Reconstruction. Lee KJ, Park SW, Jang HJ, Park DH, Kim JH, Jung JH, Koh DH, Lee J. J Clin Med. 2023 Feb 8;12(4):1353. doi: 10.3390/jcm12041353. PMID: 36835890; PMCID: PMC9966074.
15. Placement of Plastic Stents after Direct Endoscopic Necrosectomy through a Novel Lumen-Apposing Metal Stent for Effective Treatment of Laterally Extended Walled-Off Necrosis: A Pilot Study. Lee KJ, Park SW, Park DH, Kim JH, Jung JH, Koh DH, Lee J, Kim MG. J Clin Med. 2023 Jan 31;12(3):1125. doi: 10.3390/jcm12031125. PMID: 36769773; PMCID: PMC9917419.
16. Liver-Related Mortality in Hepatitis B Virus Core Antibody+/Hepatitis B Virus Surface Antigen- Patients: Occult Hepatitis B Virus, Hepatitis B Virus Reactivation, and Hepatocellular Carcinoma Development. Jung J, Nguyen MH. Am J Gastroenterol. 2023 Jan 1;118(1):24-25. doi: 10.14309/ajg.0000000000002030. Epub 2022 Sep 16. PMID: 36602834.
17. Serum S100B Levels in Patients with Liver Cirrhosis and Hepatic Encephalopathy. Kim MJ, Kim JH, Jung JH, Kim SE, Kim HS, Jang MK, Park SH, Lee MS, Suk KT, Kim DJ, Choi EK, Park JW. Diagnostics (Basel). 2023 Jan 17;13(3):333. doi: 10.3390/diagnostics13030333.
18. Platelet-to-White Blood Cell Ratio: A Feasible Biomarker for Pyogenic Liver Abscess. Ko DG, Park JW, Kim JH, Jung JH, Kim HS, Suk KT, Jang MK, Park SH, Lee MS, Kim DJ, Kim SE. Diagnostics (Basel). 2022 Oct 21;12(10):2556. doi: 10.3390/diagnostics12102556.
19. Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: Current Knowledge of Pathogenesis and Therapeutics. Park JW, Kim JH, Kim SE, Jung JH, Jang MK, Park SH, Lee MS, Kim HS, Suk KT, Kim DJ. Biomedicines. 2022 May 31;10(6):1288. doi: 10.3390/biomedicines10061288.
20. Gut microbiota-modulating agents in alcoholic liver disease: Links between host metabolism and gut microbiota. Jung JH, Kim SE, Suk KT, Kim DJ. ront Med (Lausanne). 2022 Jul 22;9:913842. doi: 10.3389/fmed.2022.913842. eCollection 2022.
21. A Multicenter Retrospective Study on Clinical Characteristics and Outcome of Pyogenic Liver Abscess Focusing Multidrug-Resistant Organisms. Park JW, Kim JH, Jung JH, Kim SE, Kim HS, Jeong H, Suk KT, Jang MK, Kim DJ, Lee MS, Park SH. J Clin Med. 2022 Feb 19;11(4):1114. doi: 10.3390/jcm11041114.
22. Ursodeoxycholic acid inhibits epithelial-mesenchymal transition, suppressing invasiveness of bile duct cancer cells: An in vitro study. Lee J, Hong EM, Kim JH, Kim JH, Jung JH, Park SW, Koh DH. Oncol Lett. 2022 Oct 26;24(6):448. doi: 10.3892/ol.2022.13568. eCollection 2022 Dec.
23. Minimal and Maximal Extent of Band Ligation for Acute Variceal Bleeding during the First Endoscopic Session. Jung JH, Jo JH, Kim SE, Bang CS, Seo SI, Park CH, Park SW. Gut Liver. 2022 Jan 15;16(1):101-110. doi: 10.5009/gnl20375.
24. Role of Microbiota-Derived Metabolites in Alcoholic and Non-Alcoholic Fatty Liver Diseases. Park JW, Kim SE, Lee NY, Kim JH, Jung JH, Jang MK, Park SH, Lee MS, Kim DJ, Kim HS, Suk KT. Int J Mol Sci. 2021 Dec 31;23(1):426. doi: 10.3390/ijms23010426.
25. Bedside Risk-Scoring Model for Predicting 6-Week Mortality in Cirrhotic Patients Undergoing Endoscopic Band Ligation for Acute Variceal Bleeding. Kim JH, Park SW, Jung JH, Park DH, Bang CS, Park CH, Park JW, Park JG. J Gastroenterol Hepatol. 2021 Feb 4. doi: 10.1111/jgh.15426.
26. Comparison of the Diagnostic Performance of Novel Slim Biopsy Forceps with Conventional Biopsy Forceps for Biliary Stricture: A Multicenter Retrospective Study. Jung ES, Park SW, Kim JH, Jung JH, Yang MJ, Park DH. J Pers Med. 2021 Jan 17;11(1):55. doi: 10.3390/jpm11010055.
27. HCC risk post-SVR with DAAs in East Asians: findings from the REAL-C cohort. Tanaka Y, Ogawa E, Huang CF, Toyoda H, Jun DW, Tseng CH, Hsu YC, Enomoto M, Takahashi H, Furusyo N, Yeh ML, Iio E, Yasuda S, Lam CP, Lee DH, Haga H, Yoon EL, Ahn SB, Wong G, Nakamuta M, Nomura H, Tsai PC, Jung JH, Song DS, Dang H, Maeda M, Henry L, Cheung R, Yuen MF, Ueno Y, Eguchi Y, Tamori A, Yu ML, Hayashi J, Nguyen MH; REAL-C Investigators. Hepatol Int. 2020 Dec;14(6):1023-1033. doi: 10.1007/s12072-020-10105-2.
28. The role of linked color imaging in endoscopic diagnosis of Helicobacter pylori associated gastritis. Lee SP, Lee J, Kae SH, Jang HJ, Koh DH, Jung JH, Byeon SJ. Scand J Gastroenterol. 2020 Sep;55(9):1114-1120. doi: 10.1080/00365521.2020.1794025.
29. Clinical outcomes of sedation during emergency endoscopic band ligation for variceal bleeding: Multicenter cohort study. Park CH, Park SW, Jung JH, Kim GG, Choi SY, Kim ES, In DH, Kim HD. Dig Endosc. 2020 Sep;32(6):894-903. doi: 10.1111/den.13610.
30. Neurologic Safety of Etomidate-Based Sedation during Upper Endoscopy in Patients with Liver Cirrhosis Compared with Propofol: A Double-Blind, Randomized Controlled Trial. Jung JH, Hyun B, Lee J, Koh DH, Kim JH, Park SW. J Clin Med. 2020 Jul 29;9(8):2424. doi: 10.3390/jcm9082424.
31. Comparative efficacy of stents in endoscopic ultrasonography-guided peripancreatic fluid collection drainage: A systematic review and network meta-analysis. Park CH, Park SW, Nam E, Jung JH, Jo JH. J Gastroenterol Hepatol. 2020 Jun;35(6):941-952. doi: 10.1111/jgh.14960.
32. Identification of risk factors for obstructive cholecystitis following placement of biliary stent in unresectable malignant biliary obstruction: a 5-year retrospective analysis in single center. Jung JH, Park SW, Hyun B, Lee J, Koh DH, Chung D. Surg Endosc. 2020 Jun 15. doi: 10.1007/s00464-020-07694-2.
33. Metformin Induces Apoptosis and Inhibits Proliferation through the AMP-Activated Protein Kinase and Insulin-like Growth Factor 1 Receptor Pathways in the Bile Duct Cancer Cells. Lee J, Hong EM, Kim JH, Jung JH, Park SW, Koh DH, Choi MH, Jang HJ, Kae SH. J Cancer. 2019 Apr 5;10(7):1734-1744. doi: 10.7150/jca.26380.
34. Efficacy of submucosal bupivacaine injection for pain relief after endoscopic submucosal dissection: A multicenter, prospective, randomized controlled, and double-blind trial. Jung JH, Jang HJ, Bang CS, Baik GH, Park SW. Medicine (Baltimore). 2019 Apr;98(17):e15360. doi: 10.1097/MD.0000000000015360.
35. Safety and efficacy of early feeding based on clinical assessment at 4 hours after ERCP: a prospective randomized controlled trial. Park CH, Jung JH, Hyun B, Kan HJ, Lee J, Kae SH, Jang HJ, Koh DH, Choi MH, Chung MJ, Bang S, Park SW. Gastrointest Endosc. 2018 Apr;87(4):1040-1049.e1. doi: 10.1016/j.gie.2017.09.021.
36. Endoscopic mucosal resection for intraductal growing-type intrahepatic cholangiocarcinoma under direct peroral cholangioscopy. Jung JH, Park SW, Shin E. Dig Endosc. 2018 Nov;30(6):785-788. doi: 10.1111/den.13256.
37. Comparative efficacy of various endoscopic techniques for the treatment of common bile duct stones: a network meta-analysis. Park CH, Jung JH, Nam E, Kim EH, Kim MG, Kim JH, Park SW. Gastrointest Endosc. 2018 Jan;87(1):43-57.e10. doi: 10.1016/j.gie.2017.07.038.
38. Clinical characteristics of second primary pancreatic cancer. Jo JH, Cho IR, Jung JH, Lee HS, Chung MJ, Bang S, Park SW, Chung JB, Song SY, Park JY. PLoS One. 2017 Jun 26;12(6):e0179784. doi: 10.1371/journal.pone.0179784.
39. Benefit of neoadjuvant concurrent chemoradiotherapy for locally advanced perihilar cholangiocarcinoma. Jung JH, Lee HJ, Lee HS, Jo JH, Cho IR, Chung MJ, Park JY, Park SW, Song SY, Bang S. World J Gastroenterol. 2017 May 14;23(18):3301-3308. doi: 10.3748/wjg.v23.i18.3301.
40. Combination Therapy with Capecitabine and Cisplatin as Second-Line Chemotherapy for Advanced Biliary Tract Cancer. Jung JH, Lee HS, Jo JH, Cho IR, Chung MJ, Bang S, Park SW, Song SY, Park JY. Chemotherapy. 2017;62(6):361-366. doi: 10.1159/000479425.